Exclusive: Kimia Therapeutics secures $55M to supercharge co-founder’s platform, create ‘next-generation Carmot’

Stig Hansen and his team are looking to replicate the success they had with Carmot Therapeutics, but under a different name with the same meaning …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Ex­clu­sive: Kimia Ther­a­peu­tics se­cures $55M to su­per­charge co-founder’s plat­form, cre­ate ‘next-gen­er­a­tion Car­mot’